Previous Article | Next Article 
Journal of Clinical Microbiology, August 1999, p. 2656-2662, Vol. 37, No. 8
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Disseminated Zygomycosis Due to Rhizopus
schipperae after Heatstroke
Gregory M.
Anstead,1,*
Deanna A.
Sutton,2
Elizabeth H.
Thompson,2
Irene
Weitzman,3,4
Randal A.
Otto,5 and
Sunil K.
Ahuja1
Departments of Internal
Medicine,1
Pathology,2 and
Otolaryngology,5 University of Texas
Health Science Center at San Antonio, San Antonio, Texas
78240-6200; Department of Microbiology, Arizona State
University, Tempe, Arizona 85287-17013; and
Department of Pathology in Medicine, Columbia University,
New York, New York 100274
Received 3 December 1998/Returned for modification 10 January
1999/Accepted 17 March 1999
 |
ABSTRACT |
A 21-year-old woman suffered heatstroke and developed diarrhea
while trekking across south Texas. The heatstroke was complicated by
seizures, rhabdomyolysis, pneumonia, renal failure, and disseminated intravascular coagulation. The patient's stool and blood cultures grew
Campylobacter jejuni. The patient subsequently developed paranasal and gastrointestinal zygomycosis and required surgical debridement and a prolonged course of amphotericin B. The zygomycete cultured was Rhizopus schipperae. This is only the second
isolate of R. schipperae that has been described. R. schipperae is characterized by the production of clusters of up
to 10 sporangiophores arising from simple but well-developed rhizoids.
These asexual reproductive propagules are produced on Czapek Dox agar
but are absent on routine mycology media, where only chlamydospores are
observed. Despite multiorgan failure, bacteremia, and disseminated
zygomycosis, the patient survived and had a good neurological outcome.
Heatstroke has not been previously described as a risk factor for the
development of disseminated zygomycosis.
 |
INTRODUCTION |
Campylobacters are small, curved,
motile, microaerophilic gram-negative rods. Campylobacter
jejuni is the most common cause of bacterial diarrhea in the
United States. However, C. jejuni bacteremia is uncommon;
only about 0.4% of reported C. jejuni isolates originate
from blood (1), and the bacteremia usually occurs in
patients with underlying medical conditions or at the extremes of age
(3). Likewise, disseminated infection by fungi of the order
Mucorales, known as zygomycosis, is a rare infection and typically
occurs in those immunocompromised by malignancy or renal disease
(16). Here we report a case in which exertional heatstroke
provided the setting for both disseminated zygomycosis and
Campylobacter bacteremia. The zygomycete cultured was
Rhizopus schipperae. This is only the second isolate of
R. schipperae that has been described.
 |
CASE REPORT |
In June 1998, a 21-year-old Mexican woman crossed the United
States border without documentation. She had a sore throat and cough
prior to departure. She left San Luis Potosi, México, and rode a
bus to Nuevo Laredo. With a group of men, she crossed the Rio Grande by
boat and hiked into Dimmit County, Tex. In the morning, the woman had
chills and diaphoresis. The immigrants drank from stock ponds and
walked for several hours. The high temperature on this day was 105°F,
and the woman became delirious and collapsed. She had convulsions and
was taken to a local hospital. Initial vital signs were a rectal
temperature of 107.1°F, a blood pressure of 71/44 mm Hg, a heart rate
of 123 beats per minute, and a respiration rate of 30 breaths per
minute. The patient was intubated and transferred to University
Hospital in San Antonio, Tex. The assessment was exertional heatstroke
with circulatory collapse, severe brain injury, shock liver,
rhabdomyolysis, renal insufficiency, pancreatitis, and disseminated
intravascular coagulation (DIC). Due to the probable exposure to
enteric pathogens, levofloxacin was initiated on admission after blood
and stool samples for cultures were obtained. The patient developed a
lung infiltrate on day 3, and Enterobacter cloacae and a
single colony of a Rhizopus species grew from tracheal aspirates. Blood and stool cultures grew C. jejuni. The
antibiotic was changed to meropenem. On day 3, E. cloacae
was also isolated from a blood culture.
On day 9, a 5-mm dark eschar was noted on her right nasal ala (Fig.
1A). Resection of the ala, lower lateral
cartilage, and a portion of the nasal septum was performed until
bleeding tissue was obtained (Fig. 1B). The nasal tissue showed
nonseptate fungal hyphae (Fig. 1C). Amphotericin B (AMB) was started at
1 mg/kg/day on day 9. On day 21, the patient passed bright red blood
per rectum, and her hematocrit dropped to 10%. An angiogram revealed
bleeding from the superior mesenteric artery. A resection of the
terminal ileum and ascending colon was performed. An ulcerating lesion, 5.5 by 2.5 by 1.5 cm, was found on the mucosal surface at the ileocecal
valve. Histopathological examination showed transmural necrotizing
granulomatous inflammation and vascular invasion by nonseptate hyphae
(Fig. 1D).

View larger version (147K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Necrotic lesion on nasal ala prior to surgery. (B)
Appearance of patient 1 month after surgery. (C) Branching, nonseptate
hyphae of R. schipperae in nasal mucosa. Hematoxylin-eosin
stain. Magnification, ×613. (D) Hyphae of R. schipperae in
intestinal mucosa. Gomori methenamine-silver stain. Magnification
×613. (E) Thick- and thin-walled chlamydospores of R. schipperae on PDA. Magnification, ×613. Lactophenol cotton blue
mount. (F) Cluster of sporangiophores of R. schipperae on
CDA. The arrow shows a septate rhizoid. Magnification, ×213.
Lactophenol cotton blue mount.
|
|
The patient received AMB at 1 mg/kg/day for a total of 40 days and
AMB-lipid complex (ABLC) at 5 mg/kg/day intermittently for 12 days
during periods of renal insufficiency. Two months after the heatstroke,
she has had significant neurological recovery but suffers from
dysarthria and ataxia.
 |
MATERIALS AND METHODS |
Histopathology.
Fragments of skin, soft tissue, and
cartilage from the right nasal vault and segments of the terminal ileum
and ascending colon were submitted for hematoxylin-eosin and Gomori
methenamine-silver staining.
Mycology.
Samples from the tracheal aspirates, nasal tissue,
and small intestine were initially incubated on Sabouraud dextrose agar (SDA) (BBL Microbiology Systems, Cockeysville, Md.) at 25°C. Since the cultures did not sporulate, a small portion of SDA containing fungal growth was excised and incubated in a 10% yeast extract-water culture at 35°C for 10 days in an attempt to promote sporulation (26). Cultures remained sterile, producing only large,
thick-walled, globose to somewhat irregularly shaped chlamydospores
(Fig. 1E). The nasal isolate was plated on Mycosel agar (BBL), potato
dextrose agar (PDA) (Remel, Lenexa, Kans.) (32), and SDA
plates for temperature studies at 25, 30, 45, and 50°C. Subcultures
of the nasal isolate (UH F 1746) were sent to the Fungal Testing
Laboratory, Department of Pathology, University of Texas Health Science
Center at San Antonio, for further characterization and designated
UTHSC R-3053. There, the isolate was subcultured on Czapek Dox agar
(CDA) (Remel) at 30°C, and temperature studies were repeated, but
with the addition of 35°C testing.
Antifungal susceptibility testing.
The nasal isolate was
tested to determine its susceptibilities to AMB, fluconazole (FLU),
5-fluorocytosine (5-FC), and itraconazole (ITRA). Tests were performed
by previously described macrodilution methods (22, 33, 43).
The minimum lethal concentrations (MLCs) were determined by plating
100-ml samples from the drug-free control tube, the MIC tube, and a
tube containing each concentration above the MIC on an SDA plate
incubated at 35°C. The MLC was defined as the lowest concentration of
antifungal compound resulting in five or fewer colonies on the SDA
plate (33).
 |
RESULTS |
Mycology.
Initial cultures on SDA at 25°C produced white,
sterile, floccose colonies after 4 days of incubation; the colonies
became buff colored at day 6. Temperature studies revealed good growth at 25, 30, 35, and 45°C and no growth at 50°C. The isolate also failed to grow on media containing cycloheximide. Subcultured colonies
at 25°C on PDA and SDA were white, floccose in the central portion,
and thin and effuse near the periphery. Rapid growth resulting in
numerous chlamydospores occurred on both media, but sporangia were
lacking. Chlamydospores were thin or thick walled (0.5 to 1 or 3.9 µm
wide), globose to subglobose, oval to irregularly shaped, and 10 to 40 µm in diameter (Fig. 1E). A culture in 10% yeast extract-water at
35°C was sterile after 10 days of incubation. Colonies on CDA at
30°C were white, thin, diffuse, and floccose, produced fewer numbers
of chlamydospores than at 25°C, but promoted the production of the
fruiting structures of R. schipperae Weitzman, McGough,
Rinaldi, et Della-Latta (1996). These consisted of up to 10 (usually 4 to 8) sporangiophores arising from a cluster of rhizoids (Fig. 1F,
2, and 3).
Mature sporangiophores were brown, being darker at the base,
occasionally septate, 150 to 400 µm in length, and 3 to 13 µm in
diameter. Sporangia were globose, greyish black, and up to 65 µm in
diameter; columellae were subglobose and hyaline (Fig.
4). Sporangiospores were subglobose to
oval and faintly striated in water, measuring 4.8 to 6.8 µm long by 3.9 to 5.8 µm wide (Fig. 5). Rhizoids
were pale to darker brown, mostly simple (seldom branched), and
occasionally septate (Fig. 1F). Some hyphal strands on all media were
covered by crystals (Fig. 6). The case
isolate was compared with the type isolate (UTHSC 94-538, ATCC 96514, CBS 138.95) obtained from a human lung in San Antonio, Tex., in 1996 (46). On the basis of the above features, the isolate was
identified as R. schipperae.

View larger version (124K):
[in this window]
[in a new window]
|
FIG. 2.
Cluster of sporangiophores of R. schipperae
on CDA. Magnification, ×306. Lactophenol cotton blue mount.
|
|

View larger version (96K):
[in this window]
[in a new window]
|
FIG. 3.
Rhizoids and sporangiospores of R. schipperae
on CDA. Magnification, ×306. Lactophenol cotton blue mount.
|
|

View larger version (114K):
[in this window]
[in a new window]
|
FIG. 5.
Columella and striated sporangiospores of R. schipperae on CDA. Magnification, ×613. Lactophenol cotton blue
mount.
|
|

View larger version (101K):
[in this window]
[in a new window]
|
FIG. 6.
Crystals on hyphae of R. schipperae on PDA.
Magnification, ×613. Lactophenol cotton blue mount.
|
|
Antifungal susceptibility testing.
The results of in vitro
antifungal susceptibility testing are displayed in Table
1. Based upon drug concentrations
normally achievable in patients receiving recommended dosages, the
isolate appeared resistant to all antifungal agents tested (AMB, 5-FC, FLU, and ITRA). On the basis of an observed MIC of 4 µg/ml, R. schipperae appears to be somewhat more resistant to AMB than
R. arrhizus, the most commonly isolated Rhizopus
species, for which AMB MICs are typically 0.125 to 2.0 µg/ml
(42). The MICs obtained for the azoles corroborated in vitro
data for the type isolate; the MICs of FLU and ITRA were >64 and >8
µg/ml, respectively. The patterns of resistance to azoles observed
for this fungus are similar to those seen for other Rhizopus
species and zygomycetous genera (25).
 |
DISCUSSION |
Heatstroke.
Heatstroke occurs when exposure to high ambient
temperatures produces hyperthermia and neurological dysfunction.
Heatstroke produces damage in multiple organs, causing shock, DIC,
renal failure, lung injury, lactic acidosis, and electrolyte
abnormalities. The mortality rate in heatstroke is 10 to 50%, with 7 to 14% of the survivors suffering permanent neurological impairment
(4).
Intestinal ischemia plays a central role in the pathophysiology of
heatstroke (
15). During exertion under heat stress, blood
is
shunted to exercising muscle and to the skin to dissipate heat.
Blood
flow is also maintained to the liver in order to access
glucose and to
remove lactate. However, the kidneys and intestines
suffer a decrease
in blood flow, with resultant ischemia and gut
wall damage. If the
ischemia is sufficiently prolonged, there
is increased gut wall
permeability, with leakage of endotoxin
and bacteria into the
circulation. Several cases of gram-negative
sepsis have been described
in exertional heatstroke (
17).
Pathophysiology.
The following scenario attempts to explain
why this woman experienced heatstroke while her male companions did not
and why the uncommon conditions of C. jejuni bacteremia and
zygomycosis arose in this patient. The patient's home, San Luis
Potosi, lies at an altitude of 1,877 m, and thus, despite its tropical
latitude, has a moderate climate (44). Therefore, the
patient was not acclimatized prior to departure, increasing the risk of
heatstroke (15, 40). Half of her 12-h bus ride was in a
non-air-conditioned vehicle; this situation may have also had a
detrimental effect on her heat tolerance, because heat stress is
cumulative (15).
Based on the patient's symptoms of sore throat and cough, she may have
had an antecedent upper-respiratory-tract viral infection.
Viral
infections may affect thermoregulation (
18) and alter
heat
shock protein levels (
15), thereby increasing susceptibility
to heatstroke. The episode of diaphoresis experienced early in
the
journey indicates that a preexisting fever may have been another
predisposing factor for heatstroke. Infection has previously been
suggested as a risk factor for the development of heatstroke
(
19).
In a study of 58 heatstroke survivors, 57% were noted
to have
had infections on admission (
8).
C. jejuni infection can be food-borne or waterborne
(
12), and this organism has been found in cow feces
(
45); thus, the
stock ponds from which this traveller drank
were the probable
source of exposure.
C. jejuni is
thermophilic, with an optimal
growth temperature of 42°C, and it is
also microaerophilic (
12).
Thus, it may have an increased
rate of replication at higher body
temperatures, especially in a
situation of decreased oxygen tension
in an ischemic bowel. As bowel
ischemia progressed, bowel wall
integrity was compromised, and the
organism rapidly gained egress
into the blood. Loss of intestinal
mucosal integrity has been
cited as a risk factor for
C. jejuni bacteremia (
30). The
Enterobacter bacteremia that occurred only 3 days into the patient's hospital
course further suggests a loss of bowel wall
integrity.
C. jejuni is typically susceptible to the nonspecific
bactericidal activity of the complement in human serum; thus,
C. jejuni bacteremia is uncommon (
1). However, complement
consumption
has been reported in heatstroke, as a consequence of DIC
(
6,
11). Hypocomplementemia is therefore a risk factor for
C. jejuni bacteremia (
3). This patient also
developed pancreatitis. Although
multiorgan system failure is common in
heatstroke, pancreatitis
is uncommon (
19). Pancreatitis has
been reported to occur in
6% of patients hospitalized for
Campylobacter enteritis (
29).
Thus, the
Campylobacter infection may have been the inciting factor
for
pancreatitis.
The zygomycotic fungi are ubiquitous saprobes of the air and soil and
cause spoilage of fruits and vegetables. Rhinocerebral
and paranasal
zygomycosis results from the inhalation of spores,
the deposition of
these spores on the nasal turbinates, germination
on the nasal mucosa,
and subsequent penetration by the hyphae
either directly or via the
vasculature into the sinuses, orbits,
and brain (
20,
41).
Diabetic ketoacidosis (DKA) is the most
common risk factor cited for
paranasal and rhinocerebral zygomycosis
(
28,
41). Frequent
blood gas analyses indicated that this
patient had metabolic acidosis
with compensatory respiratory alkalosis,
as observed previously in
heatstroke (
4). She also had mild
hyperglycemia; the highest
blood glucose level recorded prior
to the paranasal zygomycosis was 205 mg/dl. Nevertheless, these
abnormalities are mild compared to the
extreme metabolic derangements
that occur in DKA. Thus, other factors
may have contributed to
the development of paranasal zygomycosis.
Degeneration of the
nasal mucosa, with capillary proliferation, occurs
in heatstroke
(
2). Because the zygomycetes are angioinvasive
(
41), morphological
changes of the nasal mucosa may have
facilitated the spread of
the fungus. Complement depletion was probably
not important in
the pathogenesis of the zygomycosis, because
complement does not
have a significant inhibitory effect on zygomycetes
(
10).
Gastrointestinal zygomycosis is rare (
23,
39,
47); only five
cases were observed in a series of 32 patients with zygomycosis
over 20 years (
20). Conditions that predispose to gastrointestinal
zygomycosis are malnutrition, dehydration, DKA, aplastic anemia,
leukemia, and gastroenteritis (
21). In animal models of
zygomycosis,
damage to the gastrointestinal mucosa leads to fungal
invasion
(
7). There is one previous example of
Enterobacter bacteremia
preceding gastrointestinal
zygomycosis (
31). There are two other
factors that may have
contributed to the development of disseminated
zygomycosis: uremia,
which produces defects in neutrophil and
macrophage function
(
47), and the use of broad-spectrum antibiotics,
which
alters the usual bowel flora (
16,
21,
23).
In disseminated zygomycosis with gastrointestinal involvement, the
gastrointestinal tract is usually the primary site, with
disease
spreading hematogenously from this focus (
16); however,
there was no evidence for this process occurring in this case.
For this
patient, we propose that the nose and sinuses were the
primary site of
involvement, as indicated by the
Rhizopus found
in the
sputum culture early in the hospital course and the observation
of the
paranasal process about 10 days before the recognition
of the
gastrointestinal disease. Apparently, postnasal secretions
containing
fungi were swallowed, and these organisms invaded the
colonic mucosa
previously damaged by heatstroke and
C. jejuni.
In vitro antifungal susceptibility.
Currently, AMB is the only
antifungal agent with clinical utility in the treatment of zygomycosis
(25). Although the in vitro data for AMB suggested
resistance, the incidence of infections with mold pathogens is
sufficiently low that strict correlation of antifungal MICs with
clinical results of antifungal treatment has not yet been established
(24).
With early diagnosis, metabolic stabilization, aggressive debridement,
and administration of AMB, survival for zygomycosis
restricted to a
single site has increased to 73 to 80% (
27,
41). However,
disseminated zygomycosis, defined as infection
occurring in two or more
noncontiguous organ systems, has a grim
prognosis. In a series of 185 cases reviewed by Ingram et al.
(
16), only five patients
survived. This patient received prolonged
therapy with conventional AMB
at 1 mg/kg/day before susceptibility
results were available. The
patient also received ABLC at 5 mg/kg/day
for 12 days; such lipid
preparations permit higher doses to be
tolerated (
14).
Administration of ABLC, prolonged treatment
with conventional AMB,
aggressive surgical debridement, and resolution
of metabolic
abnormalities all provided sufficient conditions
for eradication of the
fungus.
Taxonomy and identifying features.
R. schipperae was
first described in 1996 after the organism was obtained from bronchial
washings and lung specimens from a patient with multiple myeloma in San
Antonio, Tex. (46). This case represents only the second
isolate of R. schipperae ever described. However, we suspect
that the organism may be more common but is not often identified due to
the requirement of CDA for sporulation. The organism belongs to the
R. microsporus complex, being closely related
morphologically to R. microsporus var.
microsporus Schipper (1984) Schipper et Sampson (1994) and
sharing characteristics with R. caespitosus Schipper et
Sampson (1994) in the same complex (35-37) and with
Amylomyces rouxii Ellis, Rhodes, et Hasseltine (1976)
(9). Characteristics which differentiate these species are
displayed in Table 2. Distinguishing
features for R. schipperae include its ivory to buff color
on PDA, the production of numerous intercalary and terminal
chlamydospores on a variety of media, clusters of up to 10 short
sporangiophores arising from simple, well-developed rhizoids, the
limited range of media for the development of sporangia (especially
CDA), and striated sporangiospores. The species is named in honor of
M. A. A. Schipper for her work with the Mucorales.
Conclusions.
This case exemplifies the severe
pathophysiological disturbances that occur in heatstroke with
accompanying infectious complications. Heatstroke may alter immune
status and predispose to infection by a number of mechanisms: increased
translocation of organisms across an ischemic bowel wall, acidosis,
complement depletion secondary to DIC, and altered lymphocyte function
(5, 8, 11, 13). Heatstroke has previously been recognized as
a risk factor for gram-negative bacteremia (11, 17).
However, this is the first report of heatstroke as a setting for
disseminated zygomycosis. There is one previous example of disseminated
infection with the fungus Fusarium oxysporum in a patient
with heatstroke (40).
This case also illustrates the larger problem of severe heatstroke in
undocumented Méxican immigrants. During the 1998 Texas
heat wave,
from 1 May to 2 August, at least 47 undocumented immigrants
died from
heatstroke (
34). This patient survived six-organ dysfunction
(lungs, brain, coagulation system, liver, intestines, and pancreas)
and
four invasive infections and achieved a good neurological
outcome, but
only with intensive application of health-care
resources.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Division of
Infectious Diseases, University of Texas Health Science Center at San
Antonio, San Antonio, TX 78284. Phone: (210) 567-4666. Fax: (210)
567-4670. E-mail: anstead{at}uthscsa.edu.
 |
REFERENCES |
| 1.
|
Allos, B. M., and M. J. Blaser.
1995.
Campylobacter jejuni and the expanding spectrum of related infections.
Clin. Infect. Dis.
20:1092-1101[Medline].
|
| 2.
|
Anim, J. T.,
M. E. Baraka,
S. Al-Gamdi, and M. O. Sohaibani.
1988.
Morphological alterations in the nasal mucosa in heat stroke.
J. Environ. Pathol. Toxicol. Oncol.
8:39-47[Medline].
|
| 3.
|
Blaser, M. J.
1986.
Extraintestinal Campylobacter infections.
West. J. Med.
144:353-354[Medline].
|
| 4.
|
Bouchama, A.
1995.
Heatstroke: a new look at an ancient disease.
Intensive Care Med.
21:623-625[Medline].
|
| 5.
|
Bouchama, A.,
K. el Hussein,
C. Adra,
M. Rezeig,
E. al Shail, and S. al Sedairy.
1992.
Distribution of peripheral blood leukocytes in acute heatstroke.
J. Appl. Physiol.
73:405-409[Abstract/Free Full Text].
|
| 6.
|
Branson, H. E.,
L. L. Wyatt, and G. Schmer.
1976.
Complement consumption in acute disseminated intravascular coagulation without antecedent immunopathology.
Am. J. Clin. Pathol.
66:967-975[Medline].
|
| 7.
|
Chihaya, Y.,
K. Matsukawa,
S. Mizushima, and Y. Matsui.
1988.
Ruminant forestomach and abomasal mucormycosis under rumen acidosis.
Vet. Pathol.
25:119-123[Abstract].
|
| 8.
|
Dematte, J. E.,
K. O'Mara,
J. Buescher,
C. G. Whitney,
S. Forsythe,
T. McNamee,
R. B. Adiga, and I. M. Ndukwu.
1998.
Near-fatal heat stroke during the 1995 heat wave in Chicago.
Ann. Intern. Med.
129:173-182[Abstract/Free Full Text].
|
| 9.
|
Ellis, J. J.,
L. J. Rhodes, and C. W. Hasseltine.
1976.
The genus Amylomyces.
Mycologia
68:131-143.
|
| 10.
|
Eng, R. H. K.,
M. Corrado, and E. Chin.
1981.
Susceptibility of zygomycetes to human serum.
Sabouradia
19:111-115.
|
| 11.
|
Graber, C. D.,
R. B. Reinhold,
J. G. Berman,
R. A. Harley, and G. R. Hennigar.
1971.
Fatal heat stroke. Circulating endotoxin and gram-negative sepsis and complications.
JAMA
216:1195-1196[Abstract/Free Full Text].
|
| 12.
|
Griffiths, P. L., and R. W. A. Park.
1990.
Campylobacters associated with human diarrhoeal disease.
J. Appl. Bacteriol.
69:281-301[Medline].
|
| 13.
|
Hammami, M. M.,
A. Bouchama,
E. Shail,
H. Y. Aboul-Enein, and S. Al-Sedairy.
1998.
Lymphocyte subsets and adhesion molecules expression in heat stroke and heat stress.
J. Appl. Physiol.
84:1615-1621[Abstract/Free Full Text].
|
| 14.
|
Hiemenz, J. W., and T. J. Walsh.
1996.
Lipid formulations of amphotericin B: recent progress and future directions.
Clin. Infect. Dis.
22(Suppl. 2):S133-S144.
|
| 15.
|
Hubbard, R. W.,
S. L. Gaffin, and D. L. Squire.
1995.
Heat-related illness, p. 167-212.
In
P. S. Auerbach (ed.), Wilderness medicine, 3rd ed. The C. V. Mosby Co., St. Louis, Mo.
|
| 16.
|
Ingram, C. W.,
J. Sennesh,
J. N. Cooper, and J. R. Perfect.
1989.
Disseminated zygomycosis: report of four cases and review.
Rev. Infect. Dis.
11:741-754[Medline].
|
| 17.
|
Kay, M. A., and E. D. B. McCabe.
1990.
Escherichia coli sepsis and prolonged hypophosphatemia following exertional heat stroke.
Pediatrics
86:307-309[Abstract/Free Full Text].
|
| 18.
|
Keren, G.,
Y. Epstein, and A. Magazanik.
1981.
Temporary heat intolerance in a heatstroke patient.
Aviation Space Environ. Med.
52:116-117[Medline].
|
| 19.
|
Knochel, J. P.
1989.
Heat stroke and related disorders.
Dis. Mon.
35:306-76.
|
| 20.
|
Marchevsky, A. M.,
E. J. Bottone,
S. A. Geller, and D. K. Giger.
1980.
The changing spectrum of disease, etiology, and diagnosis of mucormycosis.
Hum. Pathol.
11:457-464[Medline].
|
| 21.
|
Mooney, J. E., and A. Wanger.
1993.
Mucormycosis of the gastrointestinal tract in children: report of a case and review of the literature.
Pediatr. Infect. Dis. J.
12:872-876[Medline].
|
| 22.
|
National Committee for Clinical Laboratory Standards.
1997.
Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M2-A.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 23.
|
Neame, P., and D. Rayner.
1960.
Mucormycosis: a report on twenty-two cases.
Arch. Pathol.
70:261-268[Medline].
|
| 24.
|
Odds, F. C.,
F. Van Gerven,
A. Espinel-Ingroff,
M. S. Barlett,
M. A. Ghannom,
M. V. Lancaster,
M. A. Pfaller,
J. H. Rex,
M. G. Rinaldi, and T. J. Walsh.
1998.
Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models.
Antimicrob. Agents Chemother.
42:282-288[Abstract/Free Full Text].
|
| 25.
|
Otcenasék, M., and V. Buchta.
1994.
In vitro susceptibility to 9 antifungal agents of 14 strains of Zygomycetes isolated from clinical specimens.
Mycopathologia
128:135-137[Medline].
|
| 26.
|
Padhye, A. A., and L. Ajello.
1988.
A simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis.
J. Clin. Microbiol.
26:1861-1863[Abstract/Free Full Text].
|
| 27.
|
Parfey, N. A.
1986.
Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases.
Medicine
65:113-123[Medline].
|
| 28.
|
Peterson, K. L.,
M. Wang,
R. F. Canalis, and E. Abemayor.
1997.
Rhinocerebral mucormycosis: evolution of the disease and treatment options.
Laryngoscope
107:855-862[Medline].
|
| 29.
|
Pitkanen, T.,
A. Ponka,
T. Peterson, and T. Kosunen.
1983.
Campylobacter enteritis in 188 hospitalized patients.
Arch. Intern. Med.
143:215-219[Abstract/Free Full Text].
|
| 30.
|
Reed, R. P.,
I. R. Friedland,
F. O. Wegerhoff, and M. Khoosal.
1996.
Campylobacter bacteremia in children.
Pediatr. Infect. Dis. J.
15:345-348[Medline].
|
| 31.
|
Reimund, E., and A. Ramos.
1994.
Disseminated neonatal gastrointestinal mucormycosis: a case report and review.
Pediatr. Pathol.
14:385-389[Medline].
|
| 32.
|
Rinaldi, M. G.
1982.
Use of potato flakes agar in clinical mycology.
J. Clin. Microbiol.
15:1159-1160[Abstract/Free Full Text].
|
| 33.
|
Rinaldi, M. G., and A. W. Howell.
1988.
Antifungal antimicrobics: laboratory evaluation, p. 325-356.
In
B. Wentworth (ed.), Diagnostic procedures for mycotic and parasitic infections, 7th ed. American Public Health Association, Washington, D.C.
|
| 34.
|
Schillert, D.
1998.
Perilous journey: immigrants say dangers are worth chance for a better life.
San-Antonio Express News
August:2:1A, 14A.
|
| 35.
|
Schipper, M. A. A.
1984.
A revision of the genus Rhizopus. I. The Rh. stolonifer group and Rh. oryzae.
Stud. Mycol. Baarn
25:1-19.
|
| 36.
|
Schipper, M. A. A., and R. A. Samson.
1994.
Miscellaneous notes on Mucoraceae.
Mycotaxon
50:475-491.
|
| 37.
|
Schipper, M. A. A., and J. A. Stalpers.
1984.
A revision of the genus Rhizopus. III. The Rhizopus microsporus group.
Stud. Mycol. Baarn
25:19-34.
|
| 38.
|
Schrier, R. W.,
J. Hano,
H. I. Keller,
R. M. Finkel,
P. F. Gilliland,
W. J. Cirksena, and P. E. Teschan.
1970.
Renal, metabolic, and circulatory responses associated with heat stress and exercise.
Ann. Intern. Med.
73:213-223.
|
| 39.
|
Singh, N.,
T. Gayowski,
J. Singh, and V. L. Vu.
1995.
Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients.
Clin. Infect. Dis.
20:617-620[Medline].
|
| 40.
|
Sturm, A. W.,
W. Grave, and W. S. Kwee.
1989.
Disseminated Fusarium oxysporum infection in patient with heatstroke.
Lancet
i:968.
|
| 41.
|
Sugar, A. M.
1992.
Mucormycosis.
Clin. Infect. Dis.
14(Suppl. 1):S126-S129.
|
| 42.
|
Sutton, D. A.,
A. W. Fothergill, and M. G. Rinaldi.
1998.
Guide to clinically significant fungi.
Williams & Wilkins, Baltimore, Md.
|
| 43.
|
Sutton, D. A.,
M. Slifkin,
R. Yakulis, and M. G. Rinaldi.
1998.
U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa.
J. Clin. Microbiol.
36:708-715[Abstract/Free Full Text].
|
| 44.
|
von Bleyleben, K., and A. von Bleyleben.
1996.
Baedeker Mexico.
Macmillan Travel, New York, N.Y.
|
| 45.
|
Waterman, S. C.,
R. W. A. Park, and A. J. Bramley.
1984.
A search for the source of Campylobacter jejuni in milk.
J. Hyg. Camb.
92:333-337.
|
| 46.
|
Weitzman, I.,
D. A. McGough,
M. G. Rinaldi, and P. Della-Latta.
1996.
Rhizopus schipperae, sp. nov., a new agent of zygomycosis.
Mycotaxon
59:217-225.
|
| 47.
|
Winkler, S.,
S. Susani,
B. Willinger,
R. Apsner,
A. R. Rosenkranz,
R. Potzi,
G. A. Berlakovich, and E. Pohanka.
1996.
Gastric mucormycosis due to Rhizopus oryzae in a renal transplant recipient.
J. Clin. Microbiol.
34:2585-2587[Abstract].
|
Journal of Clinical Microbiology, August 1999, p. 2656-2662, Vol. 37, No. 8
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Schwarz, P., Bretagne, S., Gantier, J.-C., Garcia-Hermoso, D., Lortholary, O., Dromer, F., Dannaoui, E.
(2006). Molecular Identification of Zygomycetes from Culture and Experimentally Infected Tissues. J. Clin. Microbiol.
44: 340-349
[Abstract]
[Full Text]
-
Greenberg, R. N., Mullane, K., van Burik, J.-A. H., Raad, I., Abzug, M. J., Anstead, G., Herbrecht, R., Langston, A., Marr, K. A., Schiller, G., Schuster, M., Wingard, J. R., Gonzalez, C. E., Revankar, S. G., Corcoran, G., Kryscio, R. J., Hare, R.
(2006). Posaconazole as Salvage Therapy for Zygomycosis. Antimicrob. Agents Chemother.
50: 126-133
[Abstract]
[Full Text]
-
Lin, X., Heitman, J.
(2005). Chlamydospore Formation during Hyphal Growth in Cryptococcus neoformans. Eukaryot Cell
4: 1746-1754
[Abstract]
[Full Text]
-
Ribes, J. A., Vanover-Sams, C. L., Baker, D. J.
(2000). Zygomycetes in Human Disease. Clin. Microbiol. Rev.
13: 236-301
[Abstract]
[Full Text]